Tandem has turned around. The company recently launched a new insulin pump algorithm and offers the best touch screen pump in the U.S. With international expansion just starting and a new FDA approval in sight next year, its market cap will easily double/triple. Watch out for $70 price level.
Opened a 75,000 share position at $7.22 on 4/26
SOLD today at $26.35 for a $1.4 MILLION DOLLAR PROFIT WITHIN A FEW MONTHS
I will watch the stock..
Years ago this company's old ticker symbol traded as high as $300 under a different company name.
For now, I am out...waiting until earnings...
TNDM showing Bearish divergence on the Daily, It needs a pull back since the stock has rose +1100% since February!!
I am buying put options expiring August. Holding Over earnings!!
Even if this is coming from a big dip, this at least from MA resistances, has a long good way to go. possible strong resistance at around 55.
Ride the trend.
Tandem just got FDA approval for their t:slim x2 with BASAL-IQ and will be integrating the device with Dexcom G6. Sales will begin as early as August while expansion into several international markets is ongoing. In the meantime, we should expect to see FDA approval for Control-IQ in the first half of 2019. The company will reach cash break even point next year...
We're possibly at the end of wave 5.
Keeping in mind that wave 3 was longer than wave 1, and wave 5 cannot be longer than wave 3.
I think its good opportunity for laddering the sell orders with a stop loss of 11.72 ( the same length as wave 3).
Targets woild be 9.27, 7.9 and 5,83
Tandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.
tslim X2 pump will be a huge windfall for this company. Do your own research, personally I'm building a nice position in this one. Currently Breaking out and...
TNDM had a good push today with huge volume. Money flow also had a sharp upward move. We think it will continue its uptrend from here.
* Trade Criteria *
Date First Found- January 8, 2018
Pattern/Why- Fallen angel formation; Breakout trade
Entry Target Criteria- Pull back to $3 or Break of $3.23
Exit Target Criteria- $4.20
Stop Loss Criteria- N/A
Please...
Stock price has not been fully established yet. Lots of uncertainty, meaning lots of opportunity for short term fluctuations. Stock just underwent reverse split. Currently a "low floater", but with real business operations, not just some cheap pump and dump scam from china or some bitcoin stock. Its a real company with real aspirations of survival. Only...
This curl off the bottom finally closed above the 20 day EMA on Friday. Could be the beginning of a run to the 50 day EMA. Targeting $4.00 with resistance on the way @ $3.11 and $3.46. Depending on your risk tolerance stops could be placed below support @ $2.73 or $2.50. Watch List @ TraderPix.com
